PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ)
$352.25 -4.88 (-1.3664%)
Analysed PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ) News Sources
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally
17-05-2026
fool.com
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter
17-05-2026
fool.com
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
17-05-2026
fool.com
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million
17-05-2026
fool.com
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares
17-05-2026
fool.com
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares
17-05-2026
fool.com
Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Year
21-05-2026
fool.com
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline
21-05-2026
fool.com
JPMorgan Raises its Price Target on Xenon Pharmaceuticals (XENE)
23-05-2026
yahoo.com
Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1
26-05-2026
fool.com
What is the current price of PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ)?
The current price of PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ) is $352.25.
PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ) since the previous trading day is $-4.88.
PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ) since the previous trading day is -1.3664%.
What is the most recent average sentiment score for PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ)?
The most recent average sentiment score for PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ)?
The most recent sentiment for PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ) is .
SEC-8K** Filing Available For PRAXIS PRECISION MEDICINES I (PRAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.